Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
3,694,988
Value
$93.5M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ACAD by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,694,988$93.5M<0.1%+539,828+17.1%AddedHolders
Q1 20263,155,160$70.2M<0.1%+234,186+8.0%AddedHolders
Q4 20252,920,974$78.0M<0.1%+122,840+4.4%AddedHolders
Q3 20252,798,134$59.7M<0.1%+402,534+16.8%AddedHolders
Q2 20252,395,600$51.7M<0.1%+740,230+44.7%AddedHolders
Q1 20251,655,370$27.5M<0.1%+568,530+52.3%AddedHolders
Q4 20241,086,840$19.9M<0.1%+243,082+28.8%AddedHolders
Q3 2024843,758$13.0M<0.1%+194,608+30.0%AddedHolders
Q2 2024649,150$10.5M<0.1%+649,150NewHolders
Q1 20240$00.0%−36,754−100.0%Sold outHolders
Q4 202336,754$1.15M<0.1%−56,583−60.6%ReducedHolders
Q3 202393,337$1.95M<0.1%−9,004−8.8%ReducedHolders
Q2 2023102,341$2.45M<0.1%−27,900−21.4%ReducedHolders
Q1 2023130,241$2.45M<0.1%−186,223−58.8%ReducedHolders
Q4 2022316,464$5.04M<0.1%−39,951−11.2%ReducedHolders
Q3 2022356,415$5.83M<0.1%−136,513−27.7%ReducedHolders
Q2 2022492,928$6.95M<0.1%−148,295−23.1%ReducedHolders
Q1 2022641,223$15.5M<0.1%−19,029−2.9%ReducedHolders
Q4 2021660,252$15.4M<0.1%+368,365+126.2%AddedHolders
Q3 2021291,887$4.85M<0.1%−14,109−4.6%ReducedHolders
Q2 2021305,996$7.46M<0.1%−46,821−13.3%ReducedHolders
Q1 2021352,817$9.10M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.